Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
Open Access
- 31 May 2020
- Vol. 9 (6), 1362
- https://doi.org/10.3390/cells9061362
Abstract
Novel and minimally-invasive prostate cancer (PCa)-specific biomarkers are needed to improve diagnosis and risk stratification. Here, we investigated the biomarker potential in localized and de novo metastatic PCa (mPCa) of methylated circulating tumor DNA (ctDNA) in plasma. Using the Marmal-aid database and in-house datasets, we identified three top candidates specifically hypermethylated in PCa tissue: DOCK2, HAPLN3, and FBXO30 (specificity/sensitivity: 80%–100%/75–94%). These candidates were further analyzed in plasma samples from 36 healthy controls, 61 benign prostatic hyperplasia (BPH), 102 localized PCa, and 65 de novo mPCa patients using methylation-specific droplet digital PCR. Methylated ctDNA for DOCK2/HAPLN3/FBXO30 was generally not detected in healthy controls, BPH patients, nor in patients with localized PCa despite a positive signal in 98%–100% of matched radical prostatectomy tissue samples. However, ctDNA methylation of DOCK2, HAPLN3, and/or FBXO30 was detected in 61.5% (40/65) of de novo mPCa patients and markedly increased in high- compared to low-volume mPCa (89.3% (25/28) vs. 32.1% (10/31), p < 0.001). Moreover, detection of methylated ctDNA was associated with significantly shorter time to progression to metastatic castration resistant PCa, independent of tumor-volume. These results indicate that methylated ctDNA (DOCK2/HAPLN3/FBXO30) may be potentially useful for identification of hormone-naïve mPCa patients who could benefit from intensified treatment.Keywords
Funding Information
- Innovationsfonden (068-2012-3)
- Velux Fonden (11307)
- Aarhus Universitet (NA)
This publication has 47 references indexed in Scilit:
- Marmal-aid - a database for Infinium HumanMethylation450BMC Bioinformatics, 2013
- DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate CancerJournal of Clinical Oncology, 2013
- The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR ExperimentsClinical Chemistry, 2013
- DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate CancerDNA and Cell Biology, 2012
- DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detectionThe Prostate, 2009
- Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate CancerClinical Cancer Research, 2009
- Methylation‐Specific Sequencing of GSTP1 Gene Promoter in Circulating/Extracellular DNA from Blood and Urine of Healthy Donors and Prostate Cancer PatientsAnnals of the New York Academy of Sciences, 2008
- Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain ReactionThe Journal of Molecular Diagnostics, 2008
- Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate DiseaseClinical Cancer Research, 2005
- Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing ChemotherapyJournal of Clinical Oncology, 2004